Decibel Cannabis Company Inc. (DB.V)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.00 CAD | 60.91% |
| 2022 | -0.01 CAD | -329.17% |
| 2021 | 0.00 CAD | 118.11% |
| 2020 | -0.03 CAD | 73.26% |
| 2019 | -0.10 CAD | 73.22% |
| 2018 | -0.37 CAD | -1574.21% |
| 2017 | -0.02 CAD | 25.59% |
| 2016 | -0.03 CAD | 95.05% |
| 2015 | -0.60 CAD | 28.57% |
| 2014 | -0.84 CAD | -12.0% |
| 2013 | -0.75 CAD | 55.09% |
| 2012 | -1.67 CAD | -214.38% |
| 2011 | 1.46 CAD | 24.79% |
| 2010 | 1.17 CAD | 115.9% |
| 2009 | -7.36 CAD | -966.67% |
| 2008 | -0.69 CAD | -178.41% |
| 2007 | 0.88 CAD | 135.77% |
| 2006 | -2.46 CAD | -69.66% |
| 2005 | -1.45 CAD | -38.1% |
| 2004 | -1.05 CAD | -118.75% |
| 2003 | -0.48 CAD | -20.0% |
| 2002 | -0.40 CAD | 21.57% |
| 2001 | -0.51 CAD | 22.73% |
| 2000 | -0.66 CAD | 82.45% |
| 1999 | -3.76 CAD | -165.96% |
| 1998 | 5.70 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.01 CAD | -189.29% |
| 2024 Q2 | 0.00 CAD | 103.7% |
| 2023 Q2 | -0.00 CAD | 28.57% |
| 2023 Q4 | -0.00 CAD | -380.0% |
| 2023 Q3 | 0.00 CAD | 200.0% |
| 2023 FY | - CAD | 60.91% |
| 2023 Q1 | -0.00 CAD | 82.05% |
| 2022 Q1 | -0.01 CAD | -775.0% |
| 2022 Q3 | 0.01 CAD | 346.15% |
| 2022 Q4 | -0.01 CAD | -160.94% |
| 2022 FY | - CAD | -329.17% |
| 2022 Q2 | -0.01 CAD | 51.85% |
| 2021 Q1 | 0.01 CAD | 0.0% |
| 2021 Q4 | 0.00 CAD | 164.0% |
| 2021 FY | - CAD | 118.11% |
| 2021 Q3 | -0.00 CAD | -38.89% |
| 2021 Q2 | -0.00 CAD | -118.0% |
| 2020 Q3 | -0.00 CAD | 51.25% |
| 2020 FY | - CAD | 73.26% |
| 2020 Q4 | - CAD | 100.0% |
| 2020 Q1 | -0.01 CAD | 0.0% |
| 2020 Q2 | -0.01 CAD | 17.53% |
| 2019 Q3 | -0.09 CAD | -233.46% |
| 2019 Q1 | -0.07 CAD | 0.0% |
| 2019 Q2 | -0.03 CAD | 61.02% |
| 2019 FY | - CAD | 73.22% |
| 2019 Q4 | - CAD | 100.0% |
| 2018 Q1 | -0.01 CAD | 90.59% |
| 2018 FY | - CAD | -1574.21% |
| 2018 Q2 | - CAD | 100.0% |
| 2018 Q3 | -0.05 CAD | 0.0% |
| 2017 Q1 | -0.00 CAD | 42.86% |
| 2017 FY | - CAD | 25.59% |
| 2017 Q4 | -0.08 CAD | -2842.31% |
| 2017 Q3 | -0.00 CAD | 0.0% |
| 2017 Q2 | - CAD | 100.0% |
| 2016 Q3 | -0.01 CAD | 0.0% |
| 2016 Q4 | -0.00 CAD | 56.25% |
| 2016 FY | - CAD | 95.05% |
| 2016 Q1 | -0.00 CAD | 44.0% |
| 2016 Q2 | - CAD | 100.0% |
| 2015 Q1 | -0.04 CAD | 11.25% |
| 2015 FY | - CAD | 28.57% |
| 2015 Q3 | -0.01 CAD | 0.0% |
| 2015 Q4 | -0.01 CAD | 62.96% |
| 2015 Q2 | - CAD | 100.0% |
| 2014 Q2 | - CAD | 100.0% |
| 2014 Q3 | -0.06 CAD | 0.0% |
| 2014 Q1 | -0.15 CAD | 46.43% |
| 2014 Q4 | -0.05 CAD | 21.0% |
| 2014 FY | - CAD | -12.0% |
| 2013 Q4 | -0.28 CAD | -180.0% |
| 2013 FY | - CAD | 55.09% |
| 2013 Q2 | - CAD | 100.0% |
| 2013 Q3 | -0.10 CAD | 0.0% |
| 2013 Q1 | -0.75 CAD | -108.33% |
| 2012 Q3 | 0.58 CAD | 0.0% |
| 2012 Q1 | -0.68 CAD | -864.04% |
| 2012 FY | - CAD | -214.38% |
| 2012 Q4 | -0.36 CAD | -162.07% |
| 2012 Q2 | - CAD | 100.0% |
| 2011 FY | - CAD | 24.79% |
| 2011 Q4 | 0.09 CAD | -5.32% |
| 2011 Q3 | 0.09 CAD | 0.0% |
| 2011 Q2 | - CAD | 100.0% |
| 2011 Q1 | -1.36 CAD | -138.75% |
| 2010 Q4 | 3.51 CAD | 1110.34% |
| 2010 Q3 | 0.29 CAD | 0.0% |
| 2010 FY | - CAD | 115.9% |
| 2010 Q2 | - CAD | -100.0% |
| 2010 Q1 | 0.29 CAD | 216.0% |
| 2009 Q3 | 0.58 CAD | 0.0% |
| 2009 FY | - CAD | -966.67% |
| 2009 Q4 | -0.25 CAD | -143.1% |
| 2009 Q2 | - CAD | 100.0% |
| 2009 Q1 | -7.31 CAD | -11503.17% |
| 2008 FY | - CAD | -178.41% |
| 2008 Q1 | -0.29 CAD | 6.45% |
| 2008 Q2 | - CAD | 100.0% |
| 2008 Q3 | 0.06 CAD | 0.0% |
| 2008 Q4 | -0.06 CAD | -202.27% |
| 2007 Q3 | -0.28 CAD | 0.0% |
| 2007 Q4 | -0.31 CAD | -10.71% |
| 2007 Q2 | - CAD | 100.0% |
| 2007 Q1 | -0.33 CAD | 74.81% |
| 2007 FY | - CAD | 135.77% |
| 2006 Q2 | - CAD | 100.0% |
| 2006 Q3 | -0.17 CAD | 0.0% |
| 2006 Q1 | -0.43 CAD | 43.42% |
| 2006 FY | - CAD | -69.66% |
| 2006 Q4 | -1.31 CAD | -670.59% |
| 2005 Q4 | -0.76 CAD | -4397.04% |
| 2005 Q1 | -0.58 CAD | 31.76% |
| 2005 Q3 | -0.02 CAD | 0.0% |
| 2005 Q2 | - CAD | 100.0% |
| 2005 FY | - CAD | -38.1% |
| 2004 Q2 | - CAD | 100.0% |
| 2004 Q4 | -0.85 CAD | -347.37% |
| 2004 Q3 | -0.19 CAD | 0.0% |
| 2004 FY | - CAD | -118.75% |
| 2004 Q1 | -0.21 CAD | -5.0% |
| 2003 Q3 | -0.17 CAD | 0.0% |
| 2003 FY | - CAD | -20.0% |
| 2003 Q4 | -0.20 CAD | -17.65% |
| 2003 Q1 | -0.13 CAD | 23.53% |
| 2003 Q2 | - CAD | 100.0% |
| 2002 Q4 | -0.17 CAD | -138.76% |
| 2002 Q3 | -0.07 CAD | 0.0% |
| 2002 Q1 | -0.12 CAD | 7.69% |
| 2002 FY | - CAD | 21.57% |
| 2002 Q2 | - CAD | 100.0% |
| 2001 Q4 | -0.13 CAD | -32.52% |
| 2001 Q3 | -0.10 CAD | 0.0% |
| 2001 Q2 | - CAD | 100.0% |
| 2001 Q1 | -0.05 CAD | 0.0% |
| 2001 FY | - CAD | 22.73% |
| 2000 FY | - CAD | 82.45% |
| 2000 Q2 | - CAD | 100.0% |
| 2000 Q3 | -0.09 CAD | 0.0% |
| 2000 Q1 | -0.16 CAD | 0.0% |
| 1999 FY | - CAD | -165.96% |
| 1999 Q3 | -0.32 CAD | 0.0% |
| 1998 FY | - CAD | 0.0% |
| 1998 Q3 | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -0.02 CAD | 80.804% |
| CanadaBis Capital Inc. | 0.03 CAD | 113.272% |
| Delivra Health Brands Inc. | 0.00 CAD | 238.71% |
| Entourage Health Corp. | -0.15 CAD | 97.133% |
| Lifeist Wellness Inc. | -0.58 CAD | 99.259% |
| Cannara Biotech Inc. | 0.08 CAD | 105.527% |
| Medicure Inc. | -0.09 CAD | 95.13% |
| PharmaCielo Ltd. | -0.10 CAD | 95.7% |
| Rubicon Organics Inc. | -0.03 CAD | 86.687% |
| BioSyent Inc. | 0.54 CAD | 100.796% |
| Voyageur Pharmaceuticals Ltd. | -0.01 CAD | 59.813% |